WallStSmart
SYK

Stryker Corporation

NYSE: SYK · HEALTHCARE · MEDICAL DEVICES

$312.20
+2.15% today

Updated 2026-06-12

Market cap
$112.44B
P/E ratio
33.91
P/S ratio
4.45x
EPS (TTM)
$8.65
Dividend yield
1.15%
52W range
$281 – $402
Volume
2.5M

Stryker Corporation (SYK) Stock Valuation Analysis

Fair value estimate, historical valuation range, and quality signals for SYK.

WallStSmart Verdict
Fairly
Valued

Valuation reasonably reflects current fundamentals. Limited margin of safety at these levels.

Smart Value Score: 59 / 100
P/E (TTM)
33.9x
vs 5Y median of 39.1x
PEG
1.43
Fair range
Margin of Safety
-35.20%
Fair value $223.02 vs $312.20
EV / EBITDA
19.7x

SYK historical valuation range

Where current P/E sits in SYK's own 5Y range.

NOW
26.2x
5Y Low
32.7x
25th
39.1x
Median
41.7x
75th
53.1x
5Y High
SYK is trading cheaper than 72% of the last 5Y.
28th percentile · Below median

SYK intrinsic value (DCF)

DCF-based fair value estimate vs current market price.

Current price
$312.20
Market value
Intrinsic value
$223.02
DCF estimate
Margin of safety
-35.20%
-28.6% upside to fair value

Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.

SYK valuation signals

Quick-read green flags, caution flags, and risks based on current metrics.

!
PEG in fair range
PEG of 1.43 suggests price reflects growth fairly. Neither a bargain nor overpriced.
!
P/E in mid-range
P/E sits at the 28th percentile of the 5Y range. Neither cheap nor rich historically.
Premium to fair value
Price exceeds DCF intrinsic value by 35.2%. Limited downside protection.
Weak financial quality
Piotroski F-Score of 3/9 suggests deteriorating fundamentals. Valuation requires closer scrutiny.

P/E Ratio — History

Current: 33.91x

P/S Ratio — History

Current: 4.45x

Is SYK overvalued in 2026?

Stryker Corporation (SYK) currently trades at $312.20 per share with a market capitalization of $112,439,706,000.00. Based on our multi-factor framework, the stock trades at a fair valuation with a Smart Value Score of 59/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.

The stock trades at a P/E ratio of 33.9x, below its 5-year median of 39.1x. The PEG ratio of 1.43 points to a price that reasonably reflects expected earnings growth.

Looking at its own history, SYK is currently trading cheaper than 72% of the last 5Y on P/E. This places it in the 28th percentile of its historical range, a reasonable but unremarkable position.

Our discounted cash flow model estimates SYK's intrinsic value at $223.02 per share, against the current market price of $312.20. This implies a premium to fair value of -35.20%. The current price sits well above what projected cash flows justify, implying investors are paying for growth that has not yet materialized.

Financial quality is a concern. The Piotroski F-Score of 3/9 flags weakening fundamentals that deserve closer scrutiny before the valuation case can be fully trusted.

Bottom line: SYK trades at a fair valuation on our framework, with a Smart Value Score of 59/100. The valuation is defensible but offers no obvious bargain. Patience or a better entry price may reward disciplined buyers.

Frequently asked questions

Is SYK overvalued?

SYK scores 59/100 on our Smart Value Score (Grade C+), a mixed overall profile. On valuation specifically, the DCF puts intrinsic value below the current price, so the stock is expensive on cash flow today. The score reflects growth and quality carrying it, not a cheap entry point.

What is SYK's fair value?

Our DCF model estimates SYK's intrinsic value at $223.02 per share, versus the current price of $312.20, a margin of safety of -35.20%. Fair value is the present value of the cash flows we project the business to produce, so a price above it means the market is paying up for growth the model does not yet assume.

What P/E ratio does SYK trade at?

SYK trades at a P/E of 33.9x on trailing twelve-month earnings, against a 5-year median of 39.1x. P/E is what you pay per dollar of profit, and sitting below its own median means the stock is cheaper than usual relative to its earnings.

Is SYK a buy based on valuation?

Our Smart Value rating for SYK is Hold, from a Smart Value Score of 59/100 that blends growth, quality, and valuation. The profile is balanced and best suited to investors who already have a thesis. This is research to inform your decision, not personalized financial advice.

How does SYK's valuation compare to its history?

On P/E, SYK sits in the 28th percentile of its own 5Y range, below its long-run median relative to where it has traded. A low percentile means today's multiple is near the bottom of its historical band.

What is SYK's Smart Value Score?

SYK's Smart Value Score is 59/100. It is a proprietary WallStSmart metric blending growth quality, financial health, and valuation into a single 0-100 read, and scores above 75 are rare, signaling strong multi-factor alignment.